GLYDO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glydo, and what generic alternatives are available?
Glydo is a drug marketed by Sagent Pharms Inc and is included in one NDA.
The generic ingredient in GLYDO is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Glydo
A generic version of GLYDO was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on November 18th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GLYDO?
- What are the global sales for GLYDO?
- What is Average Wholesale Price for GLYDO?
Summary for GLYDO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Patent Applications: | 5 |
| Drug Prices: | Drug price information for GLYDO |
| DailyMed Link: | GLYDO at DailyMed |
Pharmacology for GLYDO
| Drug Class | Amide Local Anesthetic Antiarrhythmic |
| Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for GLYDO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms Inc | GLYDO | lidocaine hydrochloride | JELLY;TOPICAL | 201094-001 | Apr 28, 2014 | AT | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
